Physician

Uladzislau Naidzionak, M.D.

According to 2025 Medicare claims, Uladzislau Naidzionak, M.D. (NPI: 1023246212) practices medical oncology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is SAN DIEGO ONCOLOGY MEDICAL CLINIC (NPI: 1871844522; TIN: 95-3302834) and primary practice location at 92123-2737.

Naidzionak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 170 traditional Medicare patients, billed 71,182 HCPCS/CPT codes, and received $2,025,821 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 635 prescription claims across 88 beneficiaries totaling $2,929,426 in drug costs, led by Kisqali (Ribociclib Succinate). 2023 DME data shows 11 claims. Open Payments data shows 109 records totaling $13,925. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $18,684 to $2,025,821. Similarly, Part D prescription costs have risen steadily, from $20,119 to $2,929,426. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2015 Medicare payment: $18,684 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $190,440 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $569,977 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $862,175 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $851,217 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,450,494 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,554,863 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,155,732 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,635,567 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,025,821 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015391,698$18,684
201612521,126$190,440
201712834,420$569,977
201816460,121$862,175
201919648,211$851,217
202017270,273$1,450,494
202116960,671$1,554,863
202217464,564$1,155,732
202316872,454$1,635,567
202417071,182$2,025,821

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $20,119 (USD; Tot_Drug_Cst)2016 Drug cost: $110,002 (USD; Tot_Drug_Cst)2017 Drug cost: $386,134 (USD; Tot_Drug_Cst)2018 Drug cost: $670,489 (USD; Tot_Drug_Cst)2019 Drug cost: $1,015,638 (USD; Tot_Drug_Cst)2020 Drug cost: $602,515 (USD; Tot_Drug_Cst)2021 Drug cost: $1,037,672 (USD; Tot_Drug_Cst)2022 Drug cost: $1,305,051 (USD; Tot_Drug_Cst)2023 Drug cost: $2,527,929 (USD; Tot_Drug_Cst)2024 Drug cost: $2,929,426 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153168$20,119
201649202$110,002
201761394$386,134
201867480$670,489
201964414$1,015,638
202071449$602,515
202165536$1,037,672
202281530$1,305,051
202385720$2,527,929
202488635$2,929,426

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.5K$15K2016 Medicare payment: $14,914 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $13,140 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,676 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $740 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $470 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R36$14,914
2017N/R36$13,140
2018N/R42$4,676
2019N/RN/RN/R
2020N/R24$740
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R11$470
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4551$104
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more114840$78
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes51403$68
36415Insertion of needle into vein for collection of blood sample67176$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count122835$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KisqaliRibociclib Succinate26728$438,750
VerzenioAbemaciclib25702$425,689
ErleadaApalutamide29870$419,433
LenalidomideLenalidomide30805$372,023
TagrissoOsimertinib Mesylate17510$286,223

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.109$13,925Alexion Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Uladzislau Naidzionak, M.D.?

Tedicare shows public-source Medicare data for Uladzislau Naidzionak, M.D. (NPI 1023246212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Uladzislau Naidzionak, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Uladzislau Naidzionak, M.D.?

Uladzislau Naidzionak, M.D. is linked to SAN DIEGO ONCOLOGY MEDICAL CLINIC (billing NPI 1871844522) in the available physician profile data.

Does Uladzislau Naidzionak, M.D. have Open Payments data?

Uladzislau Naidzionak, M.D. has 109 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.